Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Medpace Holdings, Inc., a leading provider of research and development services, is headquartered in the United States. Founded in 1992, the company has established itself as a key player in the clinical research industry, offering comprehensive solutions across various therapeutic areas. With a strong presence in North America, Europe, and Asia, Medpace is renowned for its integrated approach to clinical trial management, which includes regulatory consulting, clinical monitoring, and data management.
The company’s unique combination of scientific expertise and operational excellence sets it apart in the competitive landscape. Medpace has achieved significant milestones, including rapid growth and recognition for its commitment to quality and efficiency in clinical trials. As a trusted partner for pharmaceutical and biotechnology companies, Medpace continues to enhance its market position through innovative services and a client-centric focus.
-15 vs industry average
Medpace Holdings, Inc.’s score of 18 is lower than 32% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
No reported emissions data is available for Medpace Holdings, Inc. yet.
Medpace Holdings, Inc., a US-headquartered research and development services company, has committed to setting science-based targets. While no specific emissions data is available, Medpace, Inc. (with an SBTi ID of 40030777) has a "Committed" near-term target status with the Science Based Targets initiative (SBTi), as of November 2025. This commitment indicates an intention to align its emissions reductions with the goals of the Paris Agreement.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more